Holy basil (tulsi) lowers fasting glucose and improves lipid profile in adults with metabolic disease: a meta-analysis of randomized clinical trials
Jamshidi N, Da Costa C, Cohen M
Published in Journal of Functional Foods
Methodology
Meta-analysis of randomised clinical trials of tulsi supplementation in adults with metabolic disease
Key Findings
Tulsi significantly lowered fasting blood glucose and improved total cholesterol, LDL and triglycerides relative to control.
Conclusions
Tulsi produces meaningful short-term improvements in glycaemic and lipid markers in metabolic disease.
Limitations
Small number of trials, mostly Indian single-centre studies with limited blinding.
Supplements Studied
Tulsi significantly lowered fasting blood glucose and improved total cholesterol, LDL and triglycerides.
Outcomes Measured
Tulsi significantly lowered fasting blood glucose in adults with metabolic disease.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.